Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
NEO:NASDAQ
NeoGenomics, Inc.
$7.91
-3.30%
(-0.27) 1D
$7.91
0.00% (0.00)
After hours
Closed: Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEO...
Open
$8.13
High
$8.26
Low
$7.69
Mkt. cap
1.03B
Avg. vol.
1.84M
Volume
0.00
52-wk high
$13.74
52-wk low
$4.72
EPS
-$0.84
Beta
1.72
Shares outstanding
130.14M
No. of employees
2K
News stories
From sources across the web
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
168.04M
181.33M
187.80M
190.17M
Cost of goods sold
94.79M
104.47M
107.35M
106.83M
Cost of revenue
94.79M
104.47M
107.35M
106.83M
Research and development expenses
10.18M
9.02M
8.69M
9.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
87.91M
91.36M
86.95M
86.65M
Operating expense
98.09M
100.38M
95.64M
95.82M
Total operating expenses
192.88M
204.86M
202.99M
202.65M
Operating income
-24.84M
-23.53M
-15.19M
-12.48M
Other non operating income
65.00K
482.00K
-335.00K
84.00K
EBT including unusual items
-25.66M
-45.82M
-26.39M
-12.41M
EBT excluding unusual items
-22.67M
-21.72M
-14.57M
-11.47M
Income tax expense
266.00K
-724.00K
740.00K
-2.52M
Effective tax rate
-1.04%
1.58%
-2.80%
20.35%
Other operating expenses
-
-
-
-
Net income
-25.92M
-45.09M
-27.13M
-9.88M
Net profit margin
-15.43%
-24.87%
-14.45%
-5.20%
Earnings per share
-
0.03
0.03
0.06
Interest and investment income
3.72M
2.26M
1.56M
1.52M
Interest expense
-1.62M
-933.00K
-603.00K
-599.00K
Net interest expenses
2.10M
1.33M
960.00K
924.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.11M
-6.26M
1.24M
3.91M
Gain or loss from assets sale
-
-
-
31.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer